• 1. Infection Prevention and Control Department, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P. R. China;
  • 2. Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, Hubei 430071, P. R. China;
  • 3. Department of Infection Control, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
QIAO Fu, Email: qiaofu2005@gmail.com
Export PDF Favorites Scan Get Citation

Methicillin-resistant Staphylococcus aureus is one of the important pathogens of healthcare-associated infections. In order to prevent and control the transmission of the drug-resistant organism in healthcare facilities, the Healthcare Infection Society and the Infection Prevention Society jointly conducted the guidelines for the prevention and control of methicillin-resistant Staphylococcus aureus in 2021. This article introduces the guide from the background, preparation process, main prevention and control measures and further studies, and compares the guidelines with the current prevention and control measures in China, so as to provide a methodological reference for preparation of the guide for domestic infection prevention and control practitioners, and provide evidence-based prevention and control strategies for clinical practice.

Citation: WANG Ying, QIAO Fu. Interpretation of Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) Guidelines for the Prevention and Control of Meticillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities. West China Medical Journal, 2022, 37(3): 339-343. doi: 10.7507/1002-0179.202202058 Copy

  • Previous Article

    Progress in antimicrobial stewardship in intensive care units
  • Next Article

    Design and application of nucleic acid information early warning system in medical institutions in coronavirus disease 2019 regular epidemic prevention and control